Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEORGE R REISS

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1619927969
CMS profile
208887
Location
GLENDALE, AZ

General Payments · PY2018–2024

$64,369.26

  • Reported across 226 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$12,811.17

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $9,240.00 3
Travel and Lodging $1,280.87 1
Food and Beverage $1,213.79 29
Long term medical supply or device loan $1,076.51 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GLAUKOS CORPORATION $11,785.35 12
W. L. Gore & Associates, Inc. $440.00 1
Bausch & Lomb Americas Inc. $220.96 6
Ocular Therapeutix, Inc. $159.93 2
ABBVIE INC. $145.25 9
NEW WORLD MEDICAL,INC. $59.68 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,541.77 32
PY2019 $15,018.19 52
PY2020 $8,794.18 30
PY2021 $10,266.72 21
PY2022 $11,786.62 38
PY2023 $2,150.61 19
PY2024 $12,811.17 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.47 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105936632 CMS
ABBVIE INC. $28.45 05/13/2024 Food and Beverage Undisputed 01/23/2026 1105936634 CMS
ABBVIE INC. $25.60 07/02/2024 Food and Beverage Undisputed 01/23/2026 1105936636 CMS
ABBVIE INC. $16.50 08/06/2024 Food and Beverage Undisputed 01/23/2026 1105936638 CMS
ABBVIE INC. $3.67 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105936640 CMS
ABBVIE INC. $3.62 10/12/2024 Food and Beverage Undisputed 01/23/2026 1105936642 CMS
ABBVIE INC. $19.14 10/18/2024 Food and Beverage Undisputed 01/23/2026 1105936644 CMS
ABBVIE INC. $17.56 11/13/2024 Food and Beverage Undisputed 01/23/2026 1105936646 CMS
ABBVIE INC. $7.24 12/05/2024 Food and Beverage Undisputed 01/23/2026 1105936648 CMS
Bausch & Lomb Americas Inc. $21.52 06/12/2024 Food and Beverage Undisputed 01/23/2026 1140347596 CMS
Bausch & Lomb Americas Inc. $20.96 08/21/2024 Food and Beverage Undisputed 01/23/2026 1140347592 CMS
Bausch & Lomb Americas Inc. $125.00 11/07/2024 Food and Beverage Undisputed 01/23/2026 1140347590 CMS
Bausch & Lomb Americas Inc. $19.77 11/08/2024 Food and Beverage Undisputed 01/23/2026 1140347598 CMS
Bausch & Lomb Americas Inc. $24.54 12/18/2024 Food and Beverage Undisputed 01/23/2026 1140347588 CMS
Bausch & Lomb Americas Inc. $9.17 12/19/2024 Food and Beverage Undisputed 01/23/2026 1140347594 CMS
Glaukos Corporation $91.98 02/16/2024 Food and Beverage Undisputed 01/23/2026 1151994388 CMS
Glaukos Corporation $59.87 02/28/2024 Food and Beverage Undisputed 01/23/2026 1151982436 CMS
Glaukos Corporation $2,400.00 03/13/2024 Consulting Fee Undisputed 01/23/2026 1151973071 CMS
Glaukos Corporation $20.80 03/27/2024 Food and Beverage Undisputed 01/23/2026 1151982434 CMS
Glaukos Corporation $13.26 04/24/2024 Food and Beverage Undisputed 01/23/2026 1151982430 CMS
Glaukos Corporation $4.24 04/30/2024 Food and Beverage Undisputed 01/23/2026 1151982428 CMS
Glaukos Corporation $415.46 09/18/2024 Food and Beverage Undisputed 01/23/2026 1151982432 CMS
Glaukos Corporation $1,280.87 09/18/2024 Travel and Lodging Undisputed 01/23/2026 1151995430 CMS
Glaukos Corporation $6,400.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 1151973069 CMS
Glaukos Corporation $14.97 10/30/2024 Food and Beverage Undisputed 01/23/2026 1151994386 CMS
Glaukos Corporation $7.39 11/05/2024 Food and Beverage Undisputed 01/23/2026 1151994384 CMS
Glaukos Corporation $1,076.51 12/31/2024 Long term medical supply or device loan Undisputed 01/23/2026 1151995794 CMS
NEW WORLD MEDICAL,INC. $21.46 06/06/2024 Food and Beverage Undisputed 01/23/2026 1137398315 CMS
NEW WORLD MEDICAL,INC. $21.69 06/10/2024 Food and Beverage Undisputed 01/23/2026 1137398317 CMS
NEW WORLD MEDICAL,INC. $10.69 06/11/2024 Food and Beverage Undisputed 01/23/2026 1137398319 CMS
NEW WORLD MEDICAL,INC. $5.84 11/20/2024 Food and Beverage Undisputed 01/23/2026 1137400961 CMS
Ocular Therapeutix, Inc. $9.93 09/25/2024 Food and Beverage Undisputed 01/23/2026 1148198771 CMS
Ocular Therapeutix, Inc. $150.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 1148198773 CMS
W. L. Gore & Associates, Inc. $440.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1148139479 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.